A detailed history of Urban Wealth Management, LLC transactions in Bio Line Rx Ltd. stock. As of the latest transaction made, Urban Wealth Management, LLC holds 9,144 shares of BLRX stock, worth $1,828. This represents 0.04% of its overall portfolio holdings.

Number of Shares
9,144
Holding current value
$1,828
% of portfolio
0.04%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 22, 2022

BUY
$1.06 - $1.82 $9,692 - $16,642
9,144 New
9,144 $12,000

Others Institutions Holding BLRX

About BioLineRx Ltd.


  • Ticker BLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,524,500
  • Market Cap $12.3M
  • Description
  • BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials ...
More about BLRX
Track This Portfolio

Track Urban Wealth Management, LLC Portfolio

Follow Urban Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Urban Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Urban Wealth Management, LLC with notifications on news.